Louis A. Matis
2019
In 2019, Louis A. Matis earned a total compensation of $759K as Chief Development Officer at Pieris Pharmaceuticals, a 32% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $130,776 |
|---|---|
| Option Awards | $207,137 |
| Salary | $403,631 |
| Other | $17,477 |
| Total | $759,021 |
Matis received $403.6K in salary, accounting for 53% of the total pay in 2019.
Matis also received $130.8K in non-equity incentive plan, $207.1K in option awards and $17.5K in other compensation.
Rankings
In 2019, Louis A. Matis' compensation ranked 10,425th out of 13,971 executives tracked by ExecPay. In other words, Matis earned more than 25.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,425 out of 13,971 | 25th |
Division Manufacturing | 4,215 out of 5,698 | 26th |
Major group Chemicals And Allied Products | 1,629 out of 2,197 | 26th |
Industry group Drugs | 1,397 out of 1,883 | 26th |
Industry Pharmaceutical Preparations | 1,036 out of 1,395 | 26th |
Source: SEC filing on April 28, 2020.
Matis' colleagues
We found two more compensation records of executives who worked with Louis A. Matis at Pieris Pharmaceuticals in 2019.